companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

MAYR, MICHAEL MD

GUELPH-Canada

Company Name:
Corporate Name:
MAYR, MICHAEL MD
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 40 Baker St #202,GUELPH,ON,Canada 
ZIP Code:
Postal Code:
N1H4G1 
Telephone Number: 5198361455 
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
801101 
USA SIC Description:
Physicians & Surgeons 
Number of Employees:
1 to 4 
Sales Amount:
$1 to 2.5 million 
Credit History:
Credit Report:
Very Good 
Contact Person:
Michael Mayr 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
MBI CONSTRUCTION INC
MAZZOCCO MARCO DR DVM
MAYR PATRICIA DR PHYS
Next company profile:
MAYR MICHAEL DR PHYS
MAY, J DOUG MD
MAY, DWIGHT










Company News:
  • LENZ Therapeutics
    LENZ Therapeutics is is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, focused on an eye drop to treat presbyopia and provide seamless vision for the vast majority of presbyopes
  • LENZ Therapeutics, Inc. (LENZ)
    LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1 44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia
  • About Us | LENZ Therapeutics
    LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, focused on an eye drop to treat presbyopia and provide seamless vision for the vast majority of presbyopes
  • Pipeline - Lenz Therapeutics
    LENZ Therapeutics is committed to delivering scientifically innovative solutions to the eye care space We are eager to continue bringing products to market that are in line with our purpose: to free people to forget about their vision
  • LENZ Therapeutics Announces US FDA Approval of VIZZ™ for the Treatment . . .
    “The FDA approval of VIZZ is a defining moment for LENZ and represents a transformative improvement in the available treatment options for the 128 million adults living with blurry near vision in the United States
  • LENZ Therapeutics Announces FDA Acceptance of New Drug Application for . . .
    LENZ Therapeutics is a pre-commercial biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop to improve near vision in patients with presbyopia
  • Company Information - LENZ Therapeutics, Inc.
    LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1 44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia
  • LENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY . . .
    LENZ Therapeutics is a late clinical-stage biopharmaceutical company focused on developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia
  • LENZ Therapeutics Reports Second Quarter 2025 Financial Results and . . .
    LENZ Therapeutics is a pre-commercial biopharmaceutical company focused on the development and commercialization of the first and only aceclidine-based eye drop to improve near vision in patients with presbyopia
  • LENZ Therapeutics Reports Third Quarter 2025 Financial Results and . . .
    LENZ is commercializing VIZZ in the United States and continues to establish licensing partnerships internationally to provide access to VIZZ globally LENZ is headquartered in San Diego, California




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer